Methamphetamine - UCLA Integrated Substance Abuse Programs

‣ HypothesesStudy II: Major Depressive DisorderGlasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., Mooney, L.J., &Rawson, R. (under review). Depression among methamphetamine users:association with outcomes from the MTP at 3-year follow-up.• Depressive symptoms will decline during tx, , an effect thatwill vary as a function of MA use• Depression diagnoses and severity will be associatedwith poorer adherence and outcomes‣ Measures• Mini-International Neuropsychiatric Interview• Life Experiences Timeline (LET)• BDI, ASI, BSI (at baseline, discharge, and 3-yr 3FU)